Eli Lilly Australia | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,883 results for “Eli Lilly Australia”

Trials

View all 1032 →

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

20 participants · First posted Sep 22, 2023

Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

85 participants · First posted Sep 7, 2012

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

263 participants · First posted Apr 25, 2018

Drugs

View all 402 →

LAARA (Eli Lilly & Co.)

ANGPTL8 siRNA(Eli Lilly)

AHMA

Organizations

View all 556 →

ELI LILLY AUSTRALIA PTY LTD

Australia

Eli Lilly Nederland BV

Netherlands

Eli Lilly and Company

United States

News

View all 2893 →

Tirzepatide (Mounjaro) Approved in Australia for Weight Management in Comorbid Adults

Eli Lilly Abandons PBS Negotiations for Mounjaro, Leaving 450,000 Australians Without Subsidized Access

Eli Lilly Launches Legal Challenges Against Tirzepatide Generics

Page 1 of 489